
Glipibee SR-PM-2-Tablet
Marketer
Bonsai Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glipibee SR-PM-2-Tablet
Combiflex DM is a dual-action medication formulated to manage blood glucose. Used alongside diet and exercise, it enhances glycemic control in adult patients with type 2 diabetes. Its mechanism improves insulin efficiency, resulting in reduced blood sugar. Dosage and frequency for Combiflex DM should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly; however, if nearing the next scheduled dose, omit the missed one and resume the regular regimen. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing Combiflex DM, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical consultation before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption, as it may heighten the probability of adverse events.
Primary Ingredients of Glipibee SR-PM-2-Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glipibee SR-PM-2-Tablet
Managing type 2 diabetes
Major Benefits of Glipibee SR-PM-2-Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Glipibee SR-PM-2-Tablet with a meal.
Common Side effects of Glipibee SR-PM-2-Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glipibee SR-PM-2-Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glipibee SR-PM-2-Tablet with a meal.
How Glipibee SR-PM-2-Tablet works:
Glipibee SR-PM-2-Tablet combines the actions of three distinct anti-diabetic agents: glimepiride, metformin, and pioglitazone. This triple-drug approach offers enhanced blood sugar management when monotherapy or dual medication proves insufficient. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further enhances the body's sensitivity to insulin.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glipibee SR-PM-2-Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glipibee SR-PM-2-Tablet during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Glipibee SR-PM-2-Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glipibee SR-PM-2-Tablet to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Avoid using Glipibee SR-PM-2-Tablet in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glipibee SR-PM-2-Tablet; dosage modification may be necessary. Physician consultation is advised. Glipibee SR-PM-2-Tablet is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glipibee SR-PM-2-Tablet :
Should you forget a Glipibee SR-PM-2-Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Glipibee SR-PM-2-Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
